Germany · Delayed Price · Currency is EUR Sartorius Aktiengesellschaft Earnings Call Transcripts
Fiscal Year 2026
-
Sales and recurring business grew strongly in Q1 2026, with EBITDA margin resilient and cash flow up. Guidance for 2026 is confirmed, expecting 5%-9% sales growth and continued deleveraging, despite FX and geopolitical risks.
-
AGM highlighted strong 2025 financial results, strategic acquisitions, and investments in innovation and sustainability. Leadership changes and refined strategy focus on portfolio, customer experience, and operational excellence. Dividend of EUR 0.73/0.74 per share proposed.
-
Ambitious midterm targets include 8%-11% organic revenue growth and 50-75 bps annual EBITDA margin expansion, driven by innovation in single-use technologies, AI, and advanced therapies. Strategic investments in global capacity, digitalization, and customer experience underpin resilience and future growth.
Fiscal Year 2025
-
2025 saw strong recurring revenue growth, margin expansion, and improved leverage, with results exceeding guidance. 2026 guidance anticipates 5%-9% sales growth, margin above 30%, and continued investment in innovation and capacity, amid ongoing market normalization and volatility.
-
Sales grew 7.5% in constant currencies, led by strong consumables demand and margin expansion. Guidance for 2025 was specified, with group sales expected to rise 7% and EBITDA margin above 29.5%. Equipment demand remains subdued, but gradual recovery is anticipated.
-
H1 2025 delivered 6% revenue growth and 12% EBITDA growth, led by strong consumables demand, while equipment sales lagged. Guidance for 2025 is confirmed, with continued margin expansion and deleveraging, despite FX and tariff headwinds.
-
Q1 2025 delivered strong sales and margin growth, led by consumables, while equipment demand stayed soft. Guidance for 2025 is robust, with 6% sales growth and 29%-30% EBITDA margin targeted. The MatTek acquisition and regulatory shifts support innovation and future growth.
-
The AGM highlighted stable revenues, strong order growth, and continued profitability despite market volatility. Leadership transitions were announced, with a new CEO set for July 2025. Strategic investments, innovation, and sustainability remain key priorities.
Fiscal Year 2024
-
2024 results met revised guidance with robust profitability and strong order intake in consumables, while equipment sales remained weak. Free cash flow doubled, leverage improved, and 2025 is expected to bring moderate, profitable growth above market rates, with continued focus on efficiency and deleveraging.
-
Nine-month 2024 results met expectations, with robust recurring sales and strong order intake, especially in consumables, offsetting weak equipment demand. Profitability and cash flow improved, guidance for the year is confirmed, and efficiency programs are set to deliver further benefits in Q4.
-
H1 results met targets but sales and margins declined year-over-year amid ongoing market volatility and weak demand, especially for equipment. Guidance for 2024 was lowered to flat sales with a focus on efficiency gains, while long-term fundamentals remain positive.